VELARU MANDATE EXHIBIT PACK — SYNTHETIC BIOLOGY / BIOSECURITY Jurisdiction: United States (Federal) (us_federal) Modality: Text / Chat Program: Velaru Synthetic Biology / Biosecurity · United States (Federal) (galactic_synthetic_biology_us_federal) Product ID: synthetic_biology:us_federal:bundle:text Vertical: synthetic_biology Generated: 2026-08-22T00:04:25.448941Z Authority: US Federal Exhibit — Biosecurity AI Screening Pack Deadline: Federal Select Agent Program + DURC Velaru verify: https://velaru.xyz/verify EXHIBIT A — AI INVENTORY [ { "named_entity": "Velari", "slug": "velari", "ai_use_case": "AI-assisted Synthetic Biology / Biosecurity decisions", "vertical": "synthetic_biology", "risk_tier": "elevated", "external_validation": "Velaru independent receipt verification", "handler_receipt_lock": "https://velaru.onrender.com/r/4c58eac890bfd031ce2189de5a1ca9ea292a0c837f5f535daf164aef34f31e53", "compliance_state": "grace_period", "asymmetry_grade": "A", "found_scripture_export": "https://velaru.xyz/bundle/pre-dispute/d8fb129c0c0c78d05256/export.txt", "diligence_url": "https://velaru.xyz/diligence/velari" }, { "named_entity": "LinkAudit Test", "slug": "linkaudit-test", "ai_use_case": "AI-assisted Synthetic Biology / Biosecurity decisions", "vertical": "synthetic_biology", "risk_tier": "elevated", "external_validation": "Velaru independent receipt verification", "handler_receipt_lock": "https://velaru.onrender.com/r/58ddedd1974156453bc55daef6a9857d8570d56388becbb2a80bf5bac76b771b", "compliance_state": "grace_period", "asymmetry_grade": "A", "found_scripture_export": "https://velaru.xyz/bundle/pre-dispute/78aa6e3f3a84cf1a88c0/export.txt", "diligence_url": "https://velaru.xyz/diligence/linkaudit-test" }, { "named_entity": "Link Audit Co", "slug": "link-audit-co", "ai_use_case": "AI-assisted Synthetic Biology / Biosecurity decisions", "vertical": "synthetic_biology", "risk_tier": "elevated", "external_validation": "Velaru independent receipt verification", "handler_receipt_lock": "https://velaru.onrender.com/r/d00533b7b6c0495802b4250abd5c29f60bd9f2ad3fb141bba2d9a5afee5f5542", "compliance_state": "grace_period", "asymmetry_grade": "A", "found_scripture_export": "https://velaru.xyz/bundle/pre-dispute/fea572f3996c4b963779/export.txt", "diligence_url": "https://velaru.xyz/diligence/link-audit-co" } ] EXHIBIT B — GOVERNANCE FRAMEWORK { "framework": "Velaru Mandate Registry \u2014 Synthetic Biology / Biosecurity", "exhibit_authority": "US Federal Exhibit \u2014 Biosecurity AI Screening Pack", "regulatory_frameworks": [ "Federal Select Agent Program", "NIH Guidelines", "DURC Policy", "FTC Act \u00a75", "EEOC Title VII", "NAIC Model Bulletin", "EO 14179 AI policy" ], "standards_alignment": [ "POSS-2", "DRP-1", "TCB", "FRE 707 pre-compliance", "ISO 42001" ], "human_oversight": "synthesize DNA sequence", "third_party_verification": "https://velaru.xyz/verify (operator-independent)", "data_lineage": "Hash-chained Ed25519 receipts; optional RFC3161 + external anchor", "mirror_trap": "Cloud lab orders sequence \u2014 lab owns biosecurity violation, screening vendor owns API uptime SLA. \u00b7 Federal agencies disagree on AI approach \u2014 but examiners agree internal logs are insufficient.", "chain_integrity": { "depth": 420, "invariant_holds": true } } EXHIBIT D — DATA INPUTS & VALIDATION { "data_validation_method": "Cryptographic receipt per AI decision; public verify without trusting deployer, vendor, or Velaru operator", "bias_testing_proxy": "Asymmetry score from live chain signals", "model_change_control": "Policy lock registry \u2014 criteria hash frozen pre-dispute", "logging_retention": "90-day pre-dispute window minimum; permanent verify permalinks", "external_validator": "Nisaba LLC / Velaru", "validator_independence": "Client-side Ed25519 verify; BYOK tri-receipt optional", "headline_stat": "Screening AI failure = criminal liability under Select Agent regulations", "global_leaders_addressed": [ "CDC", "Ginkgo Bioworks", "Twist Bioscience", "NIH", "WHO", "NAIC", "FTC", "EEOC" ] } MIRROR TRAP (regulatory insight) Cloud lab orders sequence — lab owns biosecurity violation, screening vendor owns API uptime SLA. · Federal agencies disagree on AI approach — but examiners agree internal logs are insufficient. NERVE CARDS — WHY GLOBAL LEADERS CARE [ { "title": "DURC policy", "body": "Dual use research of concern \u2014 AI screening decision must be documented for IBC review.", "source": "vertical" }, { "title": "Sequence orders", "body": "Every synthesis order needs screening receipt \u2014 HHS 2010 framework now AI-accelerated.", "source": "vertical" }, { "title": "Insurance exclusion", "body": "Biotech policies excluding unscreened AI sequence design.", "source": "vertical" }, { "title": "[United States (Federal)] Agency pincer", "body": "FTC, CFPB, EEOC, and DOJ all active on AI \u2014 one receipt chain satisfies cross-agency discovery.", "source": "jurisdiction" }, { "title": "[United States (Federal)] Federal preemption fight", "body": "State laws filling void \u2014 multistate operators need jurisdiction-tagged receipts.", "source": "jurisdiction" }, { "title": "[Text / Chat] Modality hook", "body": "Baseline \u2014 all frameworks apply to text decisions.", "source": "modality" } ] BOOK SUMMARY: { "total_insureds": 3, "compliant": 0, "grace_period": 3, "non_compliant": 0, "expired": 0, "not_enrolled": 0, "compliant_pct": 0.0 } TAM / EXPOSURE: Synthetic biology market $80B+ · DNA synthesis screening mandatory INSURANCE LINES: Biotech E&O, Product liability DISCLAIMER: External validation evidence pack — not legal advice, not filed rate approval.